ESC Study Group of Sports Cardiology: Recommendations for participation in leisure-time physical activity and competitive sports for patients with ischaemic heart disease

European Journal of Preventive Cardiology

Volumn 13, Issue 2, 2006, Pages 137-149

  Bã¶rjesson, Mats ^a   Assanelli, Deodato ^b   Carrã, Franã§ois ^c   Dugmore, Dorian ^d   Panhuyzen Goedkoop, Nicole M ^e   Seiler, Christian ^f   Senden, Jeff ^g   Solberg, Erik E ^h  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF BRESCIA   (Italy)

^c Unitã Biologie et Mãdecine du Sport   (France)

^d Wellness Medical Center   (United Kingdom)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f BERN UNIVERSITY HOSPITAL   (Switzerland)

^g MEANDER MEDICAL CENTER   (Netherlands)

^h DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

exercise; heart failure; physiology; training

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; ALCOHOL; ANABOLIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; COCAINE; DIPYRIDAMOLE; DOBUTAMINE; HOMOCYSTEINE; LACTIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; POTASSIUM;

AEROBIC CAPACITY; ALCOHOLISM; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; ATRIOVENTRICULAR BLOCK; BLOOD PRESSURE; CARDIOLOGY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; COCAINE DEPENDENCE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DOPING; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROLYTE DISTURBANCE; ELECTRON BEAM TOMOGRAPHY; EXERCISE TEST; HEART ARREST; HEART EJECTION FRACTION; HEART INFARCTION; HEART RATE; HEART REHABILITATION; HEART VENTRICLE ARRHYTHMIA; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HOLTER MONITORING; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; LACTATE BLOOD LEVEL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEISURE; LIFESTYLE; LUNG EDEMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SILENT MYOCARDIAL ISCHEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; SPORT; ST SEGMENT; STRESS; SUBSTANCE ABUSE; SYNDROME X; TACHYCARDIA; THROMBOCYTE ADHESION; TREADMILL; UNSTABLE ANGINA PECTORIS; WALKING;

ADULT; AGED; CARDIOLOGY; CORONARY ARTERY BYPASS; EXERCISE; FEMALE; HUMANS; LEISURE ACTIVITIES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RISK ASSESSMENT; SPORTS;

EID: 33746186496     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000199494.46708.5a     Document Type: Article

References (102)

1. Task Force of the working group on cardiac rehabilitation of the European Society of Cardiology. Long-term comprehensive care of cardiac patients. Eur Heart J 1992; 13(suppl C):1–45.
2. DeBacker G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. Third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice: European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24: 1601–1610.
3. Pelliccia A, Fagard R, Bjornstad H, Anastassakis A, Arbustini E, Assanelli D, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26: 1422–1445.
4. Thompson PD, Balady GJ, Chaitman BR, Clark LT, Levine BD, Myerburg RJ. Task force 6: Coronary artery disease. J Am Coll Cardiol 2005; 45: 1348–1353.
5. Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 1997; 18: 394–413.
6. Maron BJ, Araujo CG, Thompson PD, Fletcher GF, deLuna AB, Fleg JL, et al. Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes: an advisory for healthcare professionals from the working groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 2001; 103: 327–334.
7. Pelliccia A, Saner H. Participation in leisure-time physical activities and competitive sports in patients with cardiovascular disease: how to get the benefits without incurring risks. Eur J Cardiovasc Prev Rehabil 2005; 12: 315–317.
8. Mitchell JH, Haskell W, Snell P, vanCamp SP. Task Force 8. Classification of sports. J Am Coll Cardiol 2005; 45: 1364–1367.
9. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA project populations. Lancet 2000; 355: 675–687.
10. American Heart Association. Heart and stroke facts: 1995 statistical supplement. Dallas, Texas: American Heart Association; 1994.
11. Marchioli R, Bomba E, DiPasquale A, Geraci E, Giannuzzi P, Marfisi RM, et al. A chart of post-acute myocardial infarct risk: results in the first 18 months of the GISSI follow-up study. G Ital Cardiol 1998; 28: 416–433.
12. Maron BJ, Roberts WC, McAllister HA, Rosing DR, Epstein SE. Sudden death in young athletes. Circulation 1980; 62: 218–229.
13. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Am J Cardiol 1997; 79: 134–139.
14. Weaver WD, Cobb LA, Hallstrom AP. Characteristics of survivors of exertion—non exertion related cardiac arrest: value of subsequent exercise testing. Am J Cardiol 1982; 50: 671–676.
15. Kannel WB, Doyle JT, McNamara PM, Quickenton P, Gordon T. Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation 1975; 51: 606–613.
16. Francis KT. Status of the year 2000 health goals for physical activity and fitness. Phys Ther 1999; 79: 405–414.
17. Yusuf S, Ounpuu S. Tackling the growing global burden of atherosclerotic cardiovascular diseases. Eur J Cardiovasc Prev Rehabil 2003; 10: 236–239.
18. Deedwania PC, Carbajal EV. Silent myocardial ischemia. A clinical perspective. Arch Intern Med 1991; 151: 2373–2382.
19. Beckerman J, Mathur A, Stahr S, Chun S, Froelicher V. Exercise-induced ventricular arrhythmias and cardiovascular death. Ann Noninvasive Electrocardiol 2005; 10: 47–52.
20. Agirbasli M, Martin GS, Stout JB, Jennings HS, Lea JW, Dixon JH. Myocardial bridge as a cause of thrombus formation and myocardial infarction in a young athlete. Clin Cardiol 1997; 20: 1032–1036.
21. Cregler LL. Substance abuse in sports: the impact of cocaine, alcohol, steroids, and other drugs on the heart. In: Williams RA, editor. The athlete and heart disease. Philadelphia: Lippincott, Williams and Wilkins; 1999, pp. 131–153.
22. ACSM's guidelines for exercise testing and prescription. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
23. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79: 733–743.
24. Rauramaa R, Salonen JT, Sepponen K, Salonen R, Venalainen JM, Ihanainen M. Inhibition of platelet aggregability by moderate—intensive physical exercise: a randomized clinical trial in overweight men. Circulation 1986; 74: 939–944.
25. Nortcote RJ, Evans AD, Ballantyne D. Sudden death in squash players. Lancet 1984; I: 148–151.
26. O'Donnell TF, Clowes GH. The circulation abnormalities of heat stroke. N Engl J Med 1972; 287: 734–737.
27. Wyss CA, Koepfli P, Fretz G, Seebauer M, Schirlo C, Kaufmann PA. Influence of altitude exposure on coronary flow reserve. Circulation 2003; 108: 1202–1207.
28. Parisi A, Alabiso A, Sacchetti M, DiSalvo V, DiLUigi L, Pigozzi F. Complex ventricular arrhythmia induced by overuse of potassium supplementation in a young male football player. Case report. J Sports Med Phys Fitness 2002; 42: 214–216.
29. Lange RA, Cigarroa RG, Yancy CWJ, Willard JE, Popma JJ, Sillo M. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 1989; 321: 1557–1562.
30. Heesch CM, Withelm CR, Ristich J, Adnane J, Bontempo FA, Wagner WR. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart 2000; 83: 688–695.
31. Isner JM, Estes NA 3rd, Thompson PD, Costanzo-Nordin MR, Subramanian R, Miller G, et al. Acute cardiac events temporally related to cocaine abuse. N Engl J Med 1986; 315: 1438–1443.
32. Kennedy MC, Lawrence C. Anabolic steroid abuse and cardiac death. Med J Aust 1993; 158: 346–348.
33. Hausmann R, Hammer S, Betz P. Performance enhancing drugs (doping agents) and sudden death: a case report and review of the literature. Int J Legal Med 1998; 111: 261–264.
34. Ferenchick GS. Anabolic—androgenic steroid abuse and thrombosis. Is there a connection? Med Hypotheses 1991; 35: 27–31.
35. Fletcher GF, Balady G, Blair SN, Caspersen C, Chaitman B, Epstein S, et al. Statement on exercise: benefits and recommendations for physical activity programs for all Americans: A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council of Clinical Cardiology, American Heart Association. Circulation 1996; 94: 857–862.
36. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273: 402–407.
37. Bijnen FC, Caspersen CJ, Mosterd WL. Physical activity as a risk factor for coronary heart disease: a WHO and International Society and Federation of Cardiology position statement. Bull WHO 1994; 72: 1–4.
38. Sandvik L, Erikssen J, Thaulow E, Eriksson G, Mundal R, Rodahl K. Physical fitness as a predictor of mortality of among healthy, middle-aged Norwegian men. N Engl J Med 1993; 328: 533–537.
39. Lee IM, Hsieh C, Paffenbarger RS Jr. Exercise intensity and longevity in men: the Harvard Alumni Health Study. JAMA 1995; 273: 1179–1184.
40. Uusitupa M, Lindi V, Louheranta A, Salopuro T, Lindstrom J, Tuomilehtoo J. Long-term improvement in insulin sensitivity by changing lifestyles of peoples with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study. Diabetes 2003; 52: 2532–2538.
41. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998; 280: 2001–2007.
42. Windecker S, Allemann Y, Billinger M, Pohl T, Hutter D, Orsucci T, et al. Effect of endurance training on coronary artery size and function in healthy men: an invasive followup study. Am J Physiol Heart Circ Physiol 2002; 282: H2216–2223.
43. Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 2000; 342: 454–460.
44. Walther C, Gielen S, Hambrecht R. The effect of exercise training on endothelial function in cardiovacular disease in humans. Exerc Sport Sci Rev 2004; 32: 129–134.
45. Panagiotakos DB, Kokkinos P, Manios Y, Pitsavos C. Physical activity and markers of inflammation and thrombosis related to coronary artery disease. Prev Cardiol 2004; 7: 190–194.
46. Cadroy Y, Pillard F, Sakariassen KS, Thalamas C, Boneu B, Riviere D. Strenous but not moderate exercise increases the thrombotic tendency in healthy sedentary male volunteers. J Appl Physiol 2002; 93: 829–833.
47. Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Onset Study Investigators. N Engl J Med 1993; 329: 1677–1683.
48. Maron BJ, Poliac LC, Roberts WO. Risk for sudden cardiac death associated with marathon running. J Am Coll Cardiol 1996; 28: 428–431.
49. Albert CM, Mittleman MA, Chae CU, Lee IM, Hennekens CH, Manson JE. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000; 343: 1355–1361.
50. Perk J, Veress G. Cardiac rehabilitation: applying exercise physiology in clinical practice. Eur J Appl Physiol 2000; 83: 457–462.
51. Basilico FC. Cardiovascular disease in athletes. Am J Sports Med 1999; 27: 108–121.
52. Weber TS. Environmental and infectious conditions in sports. Clin Sport Med 2003; 22: 181–196.
53. Murray R. Nutrition for the marathon and other endurance sports: environmental stress and dehydration. Med Sci Sports Exerc 1992; 9(suppl):S319–323.
54. Yasue H, Kugiyama K. Coronary spasm: clinical features and pathogenesis. Intern Med 1997; 36: 760–765.
55. Imai Y, Nobuoka S, Nagashima J, Awaya T, Aono J, Miyake F, et al. Acute myocardial infarction induced by alternating exposure to heat in sauna and rapid cooling in cold water. Cardiology 1998; 90: 299–301.
56. Tegtbur U, Meyer H, Machold H, Busse MW. Exercise recommendation and catecholamines in patients with coronary artery disease. Z Kardiol 2002; 91: 927–936.
57. ACSM's Guidelines for exercise testing and prescription, 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2000.
58. Weltman A, Snead D, Seip R, Schurrer R, Weltman J, Rutt R, et al. Percentages of maximal heart rate, heart rate reserve and VO2max for determining endurance training intensity in male runners. Int J Sports Med 1990; 11: 218–222.
59. Pollock ML, Gaesser GA, Butcher JD. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 1998; 30: 975–991.
60. Goodman LS, McKenzie DC, Taunton JE, Walters MB. Ventilatory threshold and training heart rate in exercising cardiac patients. Can J Sport Sci 1988; 13: 220–224.
61. Bodner ME, Rhodes EC, Martin AD, Coutts KD. The relationship of the heart rate deflection point to the ventilatory threshold in trained cyclists. J Strength Cond Res 2002; 16: 573–580.
62. Hofmann P, Pokan R, Preidler K, Leitner H, Szolar D, Eber B, et al. Relationship between heart rate threshold, lactate turn point, and myocardial function. Int J Sports Med 1994; 15: 232–237.
63. Vivekananthan DP, Blackstone EH, Poitier CE, Lauer MS. Heart rate recovery after exercise is a predictor of mortality. Independent of the angiographic severity of coronary disease. J Am Coll Cardiol 2003; 42: 831–838.
64. Cole CR, Foody JM, Blackstone EH, Lauer MS. Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort. Ann Intern Med 2000; 132: 552–555.
65. Wilmore JH. Exercise testing, training and beta-adrenergic blockade. Physician Sports Med 1988; 16: 45–51.
66. Wonisch M, Hofmann P, Fruhwald FM, Kraxner W, Hödl R, Pokan R, et al. Influence of beta-blocker use on percentage of target heart rate exercise prescription. Eur J Cardiovasc Prev Rehabil 2003; 10: 296–301.
67. Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF, et al. ACC/AHA Guidelines for Exercise Testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997; 30: 260–311.
68. Börjesson M, Dellborg M. Exercise-testing post-MI: still worthwhile in the interventional era? Eur Heart J 2005; 26: 105–106.
69. Nallamothu BK, Saint S, Bielak LF, Sonnad SS, Peyser PA, Rubenfire M, et al. Electron-beam computed tomography in the diagnosis of coronary artery disease: a meta-analysis. Arch Intern Med 2001; 161: 833–838.
70. Task Force on the Management of Acute Myocardial infarction of the European Society of Cardiology. Acute myocardial infarction: pre-hospital and in-hospital management. Eur Heart J 1996; 17: 43–63.
71. Braunwald E. Unstable angina. A classification. Circulation 1989; 80: 410–414.
72. Bertrand ME, Simoons ML, Fox KAA, Wallentin LC, Hamm CW, McFadden E. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2002; 23: 1809–1840.
73. Marwick TH, Case C, Short L, Thomas JD. Prediction of mortality in patients without angina. Eur Heart J 2003; 24: 1223–1230.
74. Janal MN, Glusman M, Kuhl JP, Clark WC. Are runners stoical? An examination of pain sensitivity in habitual runners and normally active controls. Pain 1994; 58: 109–116.
75. Narins CR, Zareba W, Moss AJ, Goldstein RE, Hall WJ. Clinical implications of silent versus symptomatic exercise-induced myocardial ischemia in patients with stable coronary disease. J Am Coll Cardiol 1997; 29: 756–763.
76. Third Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Myocardial infarction redefined: a consensus document. J Am Coll Cardiol 2000; 36: 959–969.
77. Malasky BR, Alpert JS. Diagnosis of myocardial injury by biochemical markers: problems and promises. Cardiol Rev 2002; 10: 306–317.
78. Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2003; 24: 28–66.
79. Kannel WB, Cupples LA, D'Agostino RB. Sudden death risk in overt coronary heart disease: the Framingham study. Am Heart J 1987; 113: 799–804.
80. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction — 2002: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation 2002; 106: 1893–1900.
81. Cobb FR, Kraus WE, Root M, Allen JD. Assessing the risk for coronary heart disease: beyond Framingham. Am Heart J 2003; 146: 572–580.
82. Jomini V, Oppliger-Pasquali S, Wietlisbach V, Rodondi N, Jotterand V, Paccaud F, et al. Contribution of major cardiovascular risk factors to familial premature coronary artery disease: The GENECARD project. J Am Coll Cardiol 2002; 40: 676–684.
83. Pezzini A, DelZotto E, Magoni M, Costa A, Archetti S, Grassi M, et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke 2003; 34: 28–33.
84. Smith SC Jr, Amsterdam E, Balady GJ, Bonow RO, Fletcher GF, Froelicher V. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group II. Circulation 2000; 101: E12–E15.
85. Aktas MK, Ozduran V, Pothier CE, Lang R, Lauer MS. Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program. JAMA 2004; 292: 1462–1468.
86. Blumenthal RS, Becker DM, Yanek LR, Aversano TR, Moy TF, Kral BG, et al. Detecting occult coronary disease in a high-risk asymptomatic population. Circulation 2003; 107: 702–707.
87. Sdringola S, Patel D, Gould KL. High prevalence of myocardial perfusion abnormalities on positron emission tomography in asymptomatic persons with a parent or sibling with coronary artery disease. Circulation 2001; 103: 496–501.
88. Fagard RH, Björnstad HH, Börjesson M, Carré F, Deligiannis A, Vanhees L. ESC Study Group of Sports Cardiology recommendations for participation in leisure-time physical activities and competitive sports for patients with hypertension. Eur J Cardiovasc Prev Rehabil 2005; 12: 326–331.
89. Rautaharju PM, Prineas RJ, Eifler WJ, Furberg CD, Neaton JD, Crow RS, et al. Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Intervention Trial experience. J Am Coll Cardiol 1986; 8: 1–10.
90. Laukkanen JA, Kurl S, Lakka TA, Tuomainen TP, Rauramaa R, Salonen R, et al. Exercise-induced silent myocardial ischemia and coronary morbidity and mortality in middle-aged men. J Am Coll Cardiol 2001; 38: 72–79.
91. Deedwania PC. Silent ischemia predicts poor outcome in high-risk healthy men. J Am Coll Cardiol 2001; 38: 80–83.
92. Faruqui AM, Maloy WC, Felner JM, Schlant RC, Logan WD, Symbas P. Symptomatic myocardial bridging of coronary artery. Am J Cardiol 1978; 41: 1305–1310.
93. Morales AR, Ramanelli R, Boucek RJ. The mural left anterior descending coronary artery, strenuous exercise and sudden death. Circulation 1980; 62: 230–237.
94. Kramer JR, Kitazume H, Proudfit WL, Sones FN. Clinical significance of isolated coronary bridges: benign and frequent condition involving the left anterior descending artery. Am Heart J 1982; 103: 283–288.
95. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris I. A variant form of angina pectoris; preliminary report. Am Heart J 1959; 27: 375–388.
96. Lanza GA, Pedrotti P, Pasceri V, Lucente M, Crea F, Maseri A. Autonomic changes associated with spontaneous coronary spasm in patients with variant angina. J Am Coll Cardiol 1996; 28: 1249–1256.
97. Kawano H, Motoyama T, Ohgushi M, Kugiyama K, Ogawa H, Yasue H. Menstrual cycle variation of myocardial ischemia in premenopausal women with variant angina. Ann Intern Med 2001; 135: 977–981.
98. Bory M, Pierron F, Panagides D, Bonnet JL, Yvorra S, Desfossez L. Coronary artery spasm in patients with normal or near normal coronary arteries. Long-term follow-up of 277 patients. Eur Heart J 1996; 17: 1015–1021.
99. Maseri A, Crea F, Kaski JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 1991; 17: 499–506.
100. Mukerji V, Beitman BD, Alpert MA. Chest pain and angiographically normal coronary arteries. Implications for treatment. Texas Heart Inst J 1993; 20: 170–179.
101. Börjesson M, Albertsson P, Dellborg M, Eliasson T, Pilhall M, Rolny P, et al. Esophageal dysfunction in syndrome X. Am J Cardiol 1998; 82: 1187–1191.
102. Radice M, Giudici V, Marinelli G. Long-term follow-up in patients with positive exercise test and angiographically normal coronary arteries (syndrome X). Am J Cardiol 1995; 75: 620–621.